AstraZeneca v the Walker Process—a real EU–US divergence or just an attempt to compare apples to oranges?

Gallasch, Sven (2011) AstraZeneca v the Walker Process—a real EU–US divergence or just an attempt to compare apples to oranges? European Competition Journal, 7 (3). pp. 505-526. ISSN 1744-1056

Full text not available from this repository.

Abstract

The article discusses a court case AstraZeneca v European Commission regarding the antitrust scrutiny and the decision of the General Court of the European Union. The case was on the misuse of the procedural rules and antitrust with reference to the intellectual property rights of the pharmaceutical industry. Information on the abuse by the European Commission with reference to the US jurisprudence and the Walker Process Doctrine developed by the US Supreme Court is also presented.

Item Type:	Article
Faculty \ School:	Faculty of Social Sciences > School of Law
Depositing User:	Pure Connector
Date Deposited:	05 Feb 2014 13:36
Last Modified:	30 Sep 2021 04:45
URI:	https://ueaeprints.uea.ac.uk/id/eprint/44773
DOI:	10.5235/ecj.v7n3.505

Actions (login required)

View Item